Act Venture Capital

Seed to Scale: The Deciphex Journey Five years ago, Donal presented a vision: using AI to transform pathology. The problem was clear - pathology underpins 90% of diagnoses and drug development, yet faces a critical global shortage of practitioners amid rising complexity. Today's funding announcement validates that vision. In just 5 years, Deciphex has achieved remarkable milestones: - €65M total raised ✅ - 150 employees ✅ - Top 10 pharma and CRO customers ✅ - 1M+ pathology slides processed ✅ We've backed every funding round, with our largest check yet in this round. This reflects our commitment to supporting transformative founders from seed to scale. While Deciphex is unique, their journey exemplifies our philosophy: identifying a bold and ambitious vision early and providing sustained support to realize that. We welcome Molten Ventures and look forward to working closely together to support Deciphex.  Donal also wished to comment on the journey together so far: "Act Venture Capital has been an unwavering partner throughout the journey, from our early vision to this new funding milestone. We chose Act for their reputation as a long-term, multi-stage investor who truly understands the challenges and opportunities of scaling ambition. Over the years, their team, led by John, has provided more than just capital; they've offered strategic insights, operational support, and a genuine commitment to our success. Their ability to match our ambition is a testament to their belief in our mission. We are proud to have Act as our partner and look forward to continuing this transformative journey together." https://lnkd.in/eBiMzgaH

As we reflect on our 30th year in business, we want to thank our partners, the founders, and the investors who continue to trust and believe in us. 2024 like any year is a rollercoaster of ups, downs and relentlessly pushing forward. We have welcomed some incredible companies and founders to the portfolio with many yet to be revealed. We have doubled down on many companies in our portfolio that we deeply believe in. As we enter 2025, we’re excited about the future of our industry and in a strong position to continue building Act VC to best serve founders and our investors. To our founders, investors and friends - thank you again.

Marketing decisions are investment decisions, the best of which are made from a mix of quantitative and qualitative data; Bounce Insights’s AI-infused platform gives global household-name brands access to consumer insights with unrivalled agility and accuracy. We have known Rónán, Charlie, Brian, Brandon and Josh for some time and continue to be impressed with their unique mix of laser focus, energy and ambition. The culture and team at Bounce Insights is special and we are glad to be a small part of it alongside a host of supportive partners. Mairéad Roche & John O'Sullivan https://lnkd.in/gv3KWvk3

- Ireland is at the foothills of opportunity. - Companies, especially in deep tech, need to raise €50 million+. - We need to be able to do that from Ireland. - Ireland can move from being this FDI-only economic engine into building companies of a similar scale in Ireland if we can match that ambition. Read more from John Flynn's interview on the Business Post 👇 https://lnkd.in/eBbQ_R5f

Act Venture Capital is at World Space Business Week 2024 🚀 We look forward to learning about future trends and meeting founders building the future of connectivity. #WSBW2024

Thank you to Scale Ireland and Avolon for hosting another excellent Annual Autumn Gathering with the Minister of Finance Jack Chambers. We were delighted to be asked to share our insights, experience and ambition for Ireland to be a global leader in innovation. Ireland has a once-in-a-lifetime opportunity in front of it - if we can be bold enough to seize it. Now is the time to be aggressive and ambitious with our growing talent pool of next-generation founders and companies.

We are delighted to be attending Enterprise Ireland’s Disruptive Technologies Innovation Fund #disruptech2024 conference. Founders fundraising - John O'Sullivan & Andrew O'Neill are both in attendance and would be happy to chat. A thank you to Jenny Fitzgerald from portfolio company Deciphex who delivered a fascinating presentation on how Deciphex is transforming pathology through AI.

TRUSTAP is delivering safety and security to online marketplace transactions. As they fuel up to drive global expansion, we welcome the TX Ventures team and incoming chair Ovidiu Solomonov. https://lnkd.in/eZhCr8mH

Welcome to the team Mairéad Roche!

Stephen, Stuart and the stellar team behind Spectrum.Life continue to execute their mission to be the leader in digital health and wellness for insurers, educators and employers. We are proud to have led each previous round of financing and now their next phase of growth. When we back an ambitious team at the earliest stage, our job is to continue to support and match that ambition. The ambition and opportunity for Spectrum.Life is immense and we look forward to supporting the road ahead. https://lnkd.in/ePxHtUzq